EATRIS ERIC- European Infrastructure for Translational Medicine Netherlands

Research

Date range: 1 March 2021 - 28 February 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for EATRIS ERIC- European Infrastructure for Translational Medicine published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for EATRIS ERIC- European Infrastructure for Translational Medicine
Count Share
2 0.05

Outputs by subject (Share)

Outputs by subject
Subject Count Share
2 0.05

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.00

Compare EATRIS ERIC- European Infrastructure for Translational Medicine with other institutions

Collaboration

Date range: 1 March 2021 - 28 February 2022

International vs. domestic collaboration by Share

  • 0.48% Domestic
  • 99.52% International

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with EATRIS ERIC- European Infrastructure for Translational Medicine by Share (1 total)

  1. EATRIS ERIC- European Infrastructure for Translational Medicine and Qiagen N.V. (0.02)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.01
    Qiagen N.V.0.01

Top 10 international collaborators with EATRIS ERIC- European Infrastructure for Translational Medicine by Share (83 total)

  1. EATRIS ERIC- European Infrastructure for Translational Medicine and National Institutes of Health (NIH) (0.28)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    National Institutes of Health (NIH)0.22
  2. EATRIS ERIC- European Infrastructure for Translational Medicine and U.S. Food and Drug Administration (USFDA) (0.26)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    U.S. Food and Drug Administration (USFDA)0.20
  3. EATRIS ERIC- European Infrastructure for Translational Medicine and F. Hoffmann-La Roche AG (0.19)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    F. Hoffmann-La Roche AG0.13
  4. EATRIS ERIC- European Infrastructure for Translational Medicine and Illumina, Inc. (0.14)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    Illumina, Inc.0.08
  5. EATRIS ERIC- European Infrastructure for Translational Medicine and Frederick National Laboratory for Cancer Research (FNLCR) (0.12)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.04
    Frederick National Laboratory for Cancer Research (FNLCR)0.08
  6. EATRIS ERIC- European Infrastructure for Translational Medicine and Fudan University (0.11)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    Fudan University0.05
  7. EATRIS ERIC- European Infrastructure for Translational Medicine and Garvan Institute of Medical Research (0.10)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    Garvan Institute of Medical Research0.04
  8. EATRIS ERIC- European Infrastructure for Translational Medicine and Cornell University (0.10)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.05
    Cornell University0.04
  9. EATRIS ERIC- European Infrastructure for Translational Medicine and The Translational Genomics Research Institute (TGen) (0.10)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.04
    The Translational Genomics Research Institute (TGen)0.05
  10. EATRIS ERIC- European Infrastructure for Translational Medicine and Loma Linda University (LLU) (0.08)
    EATRIS ERIC- European Infrastructure for Translational Medicine0.04
    Loma Linda University (LLU)0.04

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.